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Sir, The letter from Hedberg et al. (2013) is of great interest
because it addresses an important question relating to the genetic
aetiology of hereditary myopathy with early respiratory failure
(HMERF). The original report by Lange et al. (2005) indicated
that HMERF was associated with a heterozygous g.296459C4T/
p.R32450W mutation in the kinase domain of titin (TTN) (using
Genebank AJ277892 and Uniprot Q8WZ42 as the reference
sequences). Since then, no further cases of HMERF caused by
kinase domain mutations in TTN have been reported. In contrast,
only a year since the report of a mutation in the 119th fibronectin-
3 (FN3) domain of TTN causing HMERF (Ohlsson et al., 2012;
Pfeffer et al., 2012), numerous reports have confirmed an associ-
ation between the g.274375T4C/p.C30071R FN3 domain
mutation and this disease, and seven other mutations have been
reported affecting the same domain of titin (Izumi et al., 2013;
Palmio et al., 2013; Pfeffer et al., 2013; Toro et al., 2013).
Furthermore, our recent study screening 127 patients with myofi-
brillar myopathy for mutations in TTN revealed seven families with
mutations in the 119th FN3 domain, but none with kinase domain
mutations (Pfeffer et al., 2013).
Ostensibly, the patients from Lange et al.’s (2005) original
report were from three separate families, although they all
shared the same TTN haplotype (Lange et al., 2005). Therefore,
for all intents and purposes, the kinase domain variant has still
only been reported in a single HMERF family. Hedberg et al.
(2013) now report that patients from the same family described
by Lange et al. (2005) not only carry the kinase domain mutation
(g.296459C4T/p.R32450W), but also have a g.284762C4T mu-
tation in the 119th fibronectin-3 domain, predicted to cause
p.P30091L, which is known to cause HMERF on its own (Palmio
et al., 2013; Pfeffer et al., 2013). This finding should be confirmed
by the authors of the study by Lange et al. (2005), but assuming
that Hedberg et al.’s (2013) report applies to all family members,
these data suggest that the g.284762C4T/p.P30091L FN3
domain variant is the true cause of HMERF in the original study
of Lange et al. (2005). The segregation of both the FN3 and
kinase variants with the disease in these patients is likely because
of the shared TTN haplotype between the patients.
It should be noted that Lange et al. (2005) presented functional
data in support of the kinase variant’s pathogenicity by creating a
recombinant TTN kinase construct using previously published meth-
ods (Mayans et al., 1998). The catalytic activity of the mutated
construct was similar to wild-type, although binding with NBR1
was reduced. This altered NBR1 binding was postulated to be the
disease-causing mechanism for this variant. However, the construct
included only 324 amino acids from this giant protein, whose
inferred complete model includes up to 34 350 amino acids
(Uniprot Q8WZ42). We therefore do not know whether this
kinase domain variant affects the full-length protein, nor whether
the altered NBR1 binding of this particular domain is, in itself,
pathogenic.
To determine whether kinase domain variants contribute to the
pathogenesis, we sequenced the entire kinase domain (according
to Uniprot Q8WZ42, including positions p.32115–32496) in 33
HMERF patients from eight families with the g.274375T4C/
p.C30071R mutation in the 119th FN3 domain of TTN (Pfeffer
et al., 2012, 2013). Our hypothesis was that amino acid
sequence-altering variants (previously reported, or novel) would
be more prevalent in patients with HMERF than control subjects,
and/or that kinase variants would be present in HMERF patients
with more severe phenotype. Our control group consisted of 343
disease controls from 261 pedigrees (70% of whom originate
from the UK) who have had their exomes sequenced at our
centre.
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PCR was performed with ImmolaseTM (Bioline) according to
manufacturer’s protocol, using 50 ng of DNA, 0.25mM of
each oligonucleotide and 2mM MgCl2, for 30 cycles with anneal-
ing temperature of 60C. Sequencing was performed using
BigDye (Applied Biosystems) according to the manufacturer’s
protocol with an ABI 3130XL sequencer. Primer sequences are
available on request.
One HMERF patient (Patient A-III:7 from Pfeffer et al., 2012)
with the g.274375T4C/p.C30071R mutation had a protein-alter-
ing variant, g.295853G4A predicted to cause p.V32248I in the
kinase domain (listed in dbSNP as rs34924609—note this is not
the same kinase variant as the report from Lange et al., 2005). No
sequence-altering variants were found in the other 32 patients.
Given that all 33 share the same TTN haplotype (Pfeffer et al.,
2013), the g.295853G4A/p.V32248I kinase variant in Patient
A-III:7 is likely to be in trans with the FN3 domain mutation.
This patient did not have distinguishing phenotypic features com-
pared with other family members: she had proximal-predominant
skeletal muscle weakness, respiratory muscle weakness with ab-
normal pulmonary function testing, and disease onset occurred at
age 55 (onset age ranged from 33 to 71 years in this family).
Comparison of sequence variants in our control group of 343
individuals identified a sibling pair with the g.296459C4T/
p.R32450W mutation in the kinase domain (i.e. the variant asso-
ciated with HMERF in Lange et al., 2005). These patients have a
confirmed diagnosis of an autosomal recessive limb girdle muscular
dystrophy as a result of compound heterozygous CAPN3 muta-
tions, and have muscle pathology findings that are not compatible
with HMERF. The clinical picture was of juvenile onset proximal
myopathy without respiratory muscle weakness, and thus also dis-
tinct from HMERF’s described clinical spectrum. Furthermore,
sequencing of two unaffected family members from the same
family revealed the presence of the TTN g.296459C4T/
p.R32450W kinase variant in one of them. This is consistent
with the kinase variant being a neutral polymorphism, and not
the cause of disease in this family.
We agree with Hedberg et al. (2013) that mutations in the
119th fibronectin-3 domain of TTN cause HMERF, and that the
p.R32450W kinase domain variant is not sufficient to cause the
disease. The data presented here, from both patients and controls,
provide no evidence to support the role of kinase domain muta-
tions in HMERF, in keeping with public data listing the
g.296459C4T/p.R32450W variant in the kinase domain of TTN
as a single nucleotide polymorphism (rs140319117). Although cur-
rently also listed as pathogenic on the Human Gene Mutation
Database (HGMD, CM057411), we suggest that g.296459C4T/
p.R32450W should be removed from HGMD to avoid erroneous
genetic counselling advice in the future.
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